GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Mauna Kea Technologies SA (XPAR:ALMKT) » Definitions » Other Operating Expense

Mauna Kea Technologies (XPAR:ALMKT) Other Operating Expense : €-1.88 Mil (TTM As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Mauna Kea Technologies Other Operating Expense?

Mauna Kea Technologies's Other Operating Expense for the six months ended in Dec. 2023 was €-4.62 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was €-1.88 Mil.

Mauna Kea Technologies's quarterly Other Operating Expense increased from Dec. 2022 (€-4.84 Mil) to Jun. 2023 (€2.74 Mil) but then declined from Jun. 2023 (€2.74 Mil) to Dec. 2023 (€-4.62 Mil).

Mauna Kea Technologies's annual Other Operating Expense declined from Dec. 2021 (€8.54 Mil) to Dec. 2022 (€-1.56 Mil) and declined from Dec. 2022 (€-1.56 Mil) to Dec. 2023 (€-1.88 Mil).


Mauna Kea Technologies Other Operating Expense Historical Data

The historical data trend for Mauna Kea Technologies's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mauna Kea Technologies Other Operating Expense Chart

Mauna Kea Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.74 8.69 8.54 -1.56 -1.88

Mauna Kea Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.98 3.28 -4.84 2.74 -4.62

Mauna Kea Technologies Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-1.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mauna Kea Technologies Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Mauna Kea Technologies's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Mauna Kea Technologies (XPAR:ALMKT) Business Description

Traded in Other Exchanges
Address
9, rue d'Enghien, Paris, FRA, 75010
Mauna Kea Technologies SA is a medical device corporation. It is engaged in designing, developing, and marketing an imaging platform used to view tissues at a cellular level, in real-time, during standard procedures. The firm operates in the business segment of Endomicroscopy. The group's technological platform is Cellvizio which helps physicians to detect early-stage pathologies more accurately and make therapeutic decisions. It generates revenue from the sales of Cellvizio products and accessories used for medical diagnostics, research, and related services. The company sells its products in France and internationally, of which the majority of the revenue is derived from America.

Mauna Kea Technologies (XPAR:ALMKT) Headlines

No Headlines